CancerAppy is pleased to announce that some new applications are now available in their proprietary platform.
One of them is the GeneReport tool, a personalized treatment matched application, that permits score predicted treatments with patient genomic actionable information.
Oncologists and physicians involved in cancer care, can easily match genomic information from patients with therapeutic options given alone or in combination. GeneReport provides the full information that a healthcare provider need to know to offer the maximum quality care.
GeneReport can reduce time, increase accuracy and help to select the best therapeutic options from all FDA approved drugs independently of the type of cancer, based on the patient genomic information. It is a necessary tool for physician teams involved in the treatment decision-making process of cancer patients.